Renovaro Biosciences's total assets for Q3 2024 were $117.73M, an increase of 5.74% from the previous quarter. RENB total liabilities were $29.34M for the fiscal quarter, a 0.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.